NOVALGIN 0.5% INJECTION
By Novalgin
Rx
2ml Injection in a Vial

Composition
Metamizole(0.005)

Manufacturer - Sanofi India Ltd
Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072

Expires on or after
August, 2025

liver
When using NOVALGIN 0.5% INJECTION, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. Consulting your doctor before starting treatment is crucial to ensure the safe use of NOVALGIN 0.5% INJECTION. It's advised not to use this injection in patients with severe liver disease.

kidney
NOVALGIN 0.5% INJECTION requires caution in patients with kidney disease. Dosage may need adjustment, and it is not recommended for severe kidney disease. Consult your doctor before use.

alcohol
Use caution when consuming alcohol with NOVALGIN 0.5% INJECTION. It is suggested to consult your doctor.

driving
NOVALGIN 0.5% INJECTION may cause side effects that can impact driving.

pregnancy
NOVALGIN 0.5% INJECTION is considered unsafe during pregnancy. Limited human studies indicate potential harm to the developing baby. Consult your doctor to evaluate the risks and benefits before use.

breastfeeding
It is better to consult your doctor before using NOVALGIN 0.5% INJECTION during breastfeeding.
Habit Forming | No |
Chemical Class | Pyrazolone Derivatives |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's-Non-Selective COX 1&2 Inhibitors (Others) |
₹5.98
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 18-Nov-2024